Patient Guide: A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 218 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04746924
Status: ACTIVE_NOT_RECRUITING
Condition: Non-small Cell Lung Cancer, NSCLC
Phase: PHASE3

Find a Study Location Near You

This study is available at 218 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Fullerton, California
  • Los Angeles, California
  • Ocala, Florida
  • • And 215 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily